The initial management of multiple myeloma in the era of novel agents: 2021 and beyond

被引：0

作者：

Nadeem, Omar ^{[1
]}

Richardson, Paul G. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Hematol Malignancies, Boston, MD USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 02期

关键词：

OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; COMBINATION; MULTICENTER; CARFILZOMIB; DARATUMUMAB; PHASE-2;

D O I：

10.1111/bjh.17407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：213 / 215

页数：3

共 26 条

[1] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study [J].

Attal, Michel ;

Richardson, Paul G. ;

Rajkumar, S. Vincent ;

San-Miguel, Jesus ;

Beksac, Meral ;

Spicka, Ivan ;

Leleu, Xavier ;

Schjesvold, Fredrik ;

Moreau, Philippe ;

Dimopoulos, Meletios A. ;

Huang, Jeffrey Shang-Yi ;

Minarik, Jiri ;

Cavo, Michele ;

Prince, H. Miles ;

Mace, Sandrine ;

Corzo, Kathryn P. ;

Campana, Frank ;

Le-Guennec, Solenn ;

Dubin, Franck ;

Anderson, Kenneth C. .

LANCET, 2019, 394 (10214) :2096-2107

[2] Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group [J].

Cavo, Michele ;

Terpos, Evangelos ;

Nanni, Cristina ;

Moreau, Philippe ;

Lentzsch, Suzanne ;

Zweegman, Sonja ;

Hillengass, Jens ;

Engelhardt, Monika ;

Usmani, Saad Z. ;

Vesole, David H. ;

San-Miguel, Jesus ;

Kumar, Shaji K. ;

Richardson, Paul G. ;

Mikhael, Joseph R. ;

da Costa, Fernando Leal ;

Dimopoulos, Meletios-Athanassios ;

Zingaretti, Chiara ;

Abildgaard, Niels ;

Goldschmidt, Hartmut ;

Orlowski, Robert Z. ;

Chng, Wee Joo ;

Einsele, Hermann ;

Lonial, Sagar ;

Barlogie, Bart ;

Anderson, Kenneth C. ;

Rajkumar, S. Vincent ;

Durie, Brian G. M. ;

Zamagni, Elena .

LANCET ONCOLOGY, 2017, 18 (04) :E206-E217

[3]

Cazaubiel T., 2020, AM SOC HEM ANN M

[4] Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma [J].

Chari, Ajai ;

Vogl, Dan T. ;

Gavriatopoulou, Maria ;

Nooka, Ajay K. ;

Yee, Andrew J. ;

Huff, Carol A. ;

Moreau, Philippe ;

Dingli, David ;

Cole, Craig ;

Lonial, Sagar ;

Dimopoulos, Meletios ;

Stewart, A. Keith ;

Richter, Joshua ;

Vij, Ravi ;

Tuchman, Sascha ;

Raab, Marc S. ;

Weisel, Katja C. ;

Delforge, Michel ;

Cornell, Robert F. ;

Kaminetzky, David ;

Hoffman, James E. ;

Costa, Luciano J. ;

Parker, Terri L. ;

Levy, Moshe ;

Schreder, Martin ;

Meuleman, Nathalie ;

Frenzel, Laurent ;

Mohty, Mohamad ;

Choquet, Sylvain ;

Schiller, Gary ;

Comenzo, Raymond L. ;

Engelhardt, Monika ;

Illmer, Thomas ;

Vlummens, Philip ;

Doyen, Chantal ;

Facon, Thierry ;

Karlin, Lionel ;

Perrot, Aurore ;

Podar, Klaus ;

Kauffman, Michael G. ;

Shacham, Sharon ;

Li, Lingling ;

Tang, Shijie ;

Picklesimer, Carla ;

Saint-Martin, Jean-Richard ;

Crochiere, Marsha ;

Chang, Hua ;

Parekh, Samir ;

Landesman, Yosef ;

Shah, Jatin .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (08) :727-738

[5]

Dimopoulos M, 2020, LANCET, V396, P186, DOI 10.1016/S0140-6736(20)30734-0

[6] Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial [J].

Durie, Brian G. M. ;

Hoering, Antje ;

Abidi, Muneer H. ;

Rajkumar, S. Vincent ;

Epstein, Joshua ;

Kahanic, Stephen P. ;

Thakuri, Mohan ;

Reu, Frederic ;

Reynolds, Christopher M. ;

Sexton, Rachael ;

Orlowski, Robert Z. ;

Barlogie, Bart ;

Dispenzieri, Angela .

LANCET, 2017, 389 (10068) :519-527

[7] Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma [J].

Facon, T. ;

Kumar, S. ;

Plesner, T. ;

Orlowski, R. Z. ;

Moreau, P. ;

Bahlis, N. ;

Basu, S. ;

Nahi, H. ;

Hulin, C. ;

Quach, H. ;

Goldschmidt, H. ;

O'Dwyer, M. ;

Perrot, A. ;

Venner, C. P. ;

Weisel, K. ;

Mace, J. R. ;

Raje, N. ;

Attal, M. ;

Tiab, M. ;

Macro, M. ;

Frenzel, L. ;

Leleu, X. ;

Ahmadi, T. ;

Chiu, C. ;

Wang, J. ;

Van Rampelbergh, R. ;

Uhlar, C. M. ;

Kobos, R. ;

Qi, M. ;

Usmani, S. Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (22) :2104-2115

[8] Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis [J].

Gambella, Manuela ;

Omede, Paola ;

Spada, Stefano ;

Muccio, Vittorio Emanuele ;

Gilestro, Milena ;

Saraci, Elona ;

Grammatico, Sara ;

Larocca, Alessandra ;

Conticello, Concetta ;

Bernardini, Annalisa ;

Gamberi, Barbara ;

Troia, Rossella ;

Liberati, Anna Marina ;

Offidani, Massimo ;

Rocci, Alberto ;

Palumbo, Antonio ;

Cavo, Michele ;

Sonneveld, Pieter ;

Boccadoro, Mario ;

Oliva, Stefania .

CANCER, 2019, 125 (05) :750-760

[9] The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift? [J].

Kazandjian, Dickran ;

Mo, Clifton C. ;

Landgren, Ola ;

Richardson, Paul G. .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) :692-703

[10] Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial [J].

Kumar, Shaji K. ;

Jacobus, Susanna J. ;

Cohen, Adam D. ;

Weiss, Matthias ;

Callander, Natalie ;

Singh, Avina K. ;

Parker, Terri L. ;

Menter, Alexander ;

Yang, Xuezhong ;

Parsons, Benjamin ;

Kumar, Pankaj ;

Kapoor, Prashant ;

Rosenberg, Aaron ;

Zonder, Jeffrey A. ;

Faber, Edward, Jr. ;

Lonial, Sagar ;

Anderson, Kenneth C. ;

Richardson, Paul G. ;

Orlowski, Robert Z. ;

Wagner, Lynne, I ;

Rajkumar, S. Vincent .

LANCET ONCOLOGY, 2020, 21 (10) :1317-1330

← 1 2 3 →